Article citationsMore>>

H. Abolgha-semi, A. Amid, S. Zeinali, M. Radfar, P. Eshghi, M. Rahiminejad, et al., “Thalassemia in Iran Epidemiology, Prevention, and Management,” Journal of Pediatric Hematology/Oncology, Vol. 29, No. 4, 2007, pp. 233-238. doi:10.1097/MPH.0b013e3180437e02

has been cited by the following article:

• TITLE: Co-Inheritance of Beta & Delta-Globin Gene (HbYialousa) Mutations in an Iranian β-Thalassemia Carrier

  AUTHORS: Atefeh Valaei, Farnaz Eghbalpour, Zahra Kainimoghaddam, Fatemeh Bayat, Maryam Taghavi Basmanj, Morteza Karimipoor, Sirous Zeinali

  KEYWORDS: δ-Globin Gene; β-Thalassemia; HbYialousa; β-Globin Gene; CD39

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.3 No.7, December 31, 2012

  ABSTRACT: Introduction: Beta-thalassemia is characterized by absence or reduced synthesis of the β-globin. Carriers of β-thalas- semia, typically have microcytic hypochromic anemia and elevated hemoglobin HbA2 and normal HbF level. On the other hand carriers of severe alpha-thalassemia also have similar CBC parameters to that of β-thalassemia with normal HbA2 level. Co-presence of mutations in the β-globin and delta-globin genes (point mutations or deletions) usually give normal HbA2 and elevated HbF level. We report a β-thal carrier with normal level of HbA2 and increased level of HbF who had a point mutation in CD39 on the beta-globin gene and a point mutation in CD27 on the δ-globin gene named Hb-Yialousa. Materials & Methods: An individual with low hematological indices, normal HbA2 and elevated HbF was referred to our center as routine premarital screening program. Mutations in the β-globin and δ-globin genes were screened using ARMS and sequencing methods. Results: The mutation in β- and δ-globin genes were identified as CD39 and CD27 (HbYialousa) respectively. No point mutation or deletion in α-globin gene was identified. Discussion: We showed that normal HBA2 with elevated HbF level is due to co-inheritance of delta-globin gene mutation with mutation in the β-globin gene. When screening for β-thalassemia, one has to either rule out presence of α-globin gene mutation of mutation in the delta-globin gene.